InvestorsHub Logo
Followers 87
Posts 6773
Boards Moderated 1
Alias Born 09/18/2009

Re: shajandr post# 40937

Tuesday, 10/31/2023 10:16:21 AM

Tuesday, October 31, 2023 10:16:21 AM

Post# of 43159
We have the possibility of also receiving a Priority Review Voucher, or two, so we will likely be able to watch for Price Change Parity with them again, going forward.

https://www.reuters.com/business/healthcare-pharmaceuticals/bluebird-bio-sell-sickle-cell-gene-therapy-fda-voucher-103-million-if-approved-2023-10-30/
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.